Gill S, Vides V, Frey NV, et al. Anti-CD19 CAR T cells in combination with ibrutinib for the treatment of chronic lymphocytic leukemia. Blood Adv. 2022;6(21):5774-5785.

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Hematology 2023
Materias:
Erratum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10692278/
https://www.ncbi.nlm.nih.gov/pubmed/37889496
http://dx.doi.org/10.1182/bloodadvances.2023011694

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10692278/
https://www.ncbi.nlm.nih.gov/pubmed/37889496
http://dx.doi.org/10.1182/bloodadvances.2023011694

Ejemplares similares